CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
ISU Abxis Company Limited Company Snapshot
ISU Abxis Company Limited operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares ISU Abxis Company Limited with three other companies in this sector in South Korea: Corestem Inc (2018 sales of 22.32 billion Korean Won [US$19.28 million] of which 87% was The clinical trial agent), Alteogen Inc (13.70 billion Korean Won [US$11.84 million] of which 100% was Biotechnology Research&Development), and Cellumed Co Ltd (10.84 billion Korean Won [US$9.37 million] of which 100% was medical segment).

Sales Analysis. ISU Abxis Company Limited reported sales of 16.75 billion Korean Won (US$14.47 million) for the year ending December of 2018. This represents a decrease of 13.9% versus 2017, when the company's sales were 19.46 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
ISU Abxis Company Limited
  Stock Performance Chart for ISU Abxis Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 7,250.00
(Figures in Korean Won)
1 Week 3.7%   13 Weeks 6.1%  
4 Weeks 40.2%   52 Weeks 8.2%  
 
ISU Abxis Company Limited Key Data:
  Ticker: 086890 Country: Korea (South)
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 16,745,736,364
(Year Ending Jan 2019).
Employees: 155
  Currency: Korean Won Market Cap: 193,033,367,000
  Fiscal Yr Ends: December Shares Outstanding: 26,625,292
  Share Type: Common Closely Held Shares: 9,780,238
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.